We examined a cohort of BRAF‐wild‐type cancers and BRAF‐mutant cancers, further stratified by microsatellite instability status (Fig. 4C), and found KLF5 to be significantly elevated in BRAF‐mutant cancers (Fig. 4D). The gene discussed is KLF5; the disease is cancer.